Printable Cell and Gene Therapy Manufacturing Heatmap - Europe
The Road To Commercialisation with Cell and Gene Therapies
Over the last 12 months, the cell and gene therapy manufacturing sphere has matured vastly with more companies advancing to commercial products, especially with allogenic therapies. Now that the theory behind the therapy is catching up with the technology, the two can come together to progress towards producing commercial products.
Last year Pharma IQ examined Great Britain with our UK Cell and Gene Manufacturing hotspot map. This year we broaden our focus to scan the cell and gene manufacturing activity that is occurring across Europe regarding the road to commercializing these therapies.
TO READ THE FULL STORY
Please note: That all fields marked with an asterisk (*) are required.